FDA Is Working "Proactively and Creatively" on Myotrophin, Agency Says
Executive Summary
FDA is working "proactively and creatively" with Cephalon to further the review of the Myotrophin NDA, FDA's Associate Commissioner of Legislative Affairs Diane Thompson told Sen. Hatch (R-Utah) in a March 3 letter.